1. Home
  2. Labeler Index
  3. Hubei Jxbio Pharmaceutical Co., Ltd
  4. 76617-002
  5. NDC Package Code: 76617-002-01 Liraglutide

NDC Package 76617-002-01 Liraglutide

Powder - View Billable Units, 11-Digit Format, RxNorm

Table of Contents

    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is an UNFINISHED DRUG part of the official NDC directory. Unfinished drugs include products like active ingredients some of which are used in bulk for further processing or compounding. The FDA requires a list of these drugs manufactured in a U.S. commercial distribution facility.

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
76617-002-01
Package Description:
5 g in 1 BOTTLE
Product Code:
76617-002
Non-Proprietary Name:
Liraglutide
Substance Name:
Liraglutide
Usage Information:
This medication is used with a doctor-approved exercise, behavior change, and reduced-calorie diet program to help you lose weight. It is used by certain overweight people, such as those who are obese or have weight-related medical problems. Losing weight and keeping it off can lessen the many health risks that come with obesity, including heart disease, diabetes, high blood pressure, and a shorter life. Liraglutide is similar to a natural hormone in your body (incretin). It works by controlling your appetite.
11-Digit NDC Billing Format:
76617000201
Product Type:
Bulk Ingredient
Labeler Name:
Hubei Jxbio Pharmaceutical Co., Ltd
Dosage Form:
Powder - An intimate mixture of dry, finely divided drugs and/or chemicals that may be intended for internal or external use.
Active Ingredient(s):
  • LIRAGLUTIDE 1 g/g
    • Sample Package:
    N/A
    Marketing Category:
    BULK INGREDIENT FOR HUMAN PRESCRIPTION COMPOUNDING - A category specifying that a bulk product is intended for use on humans and requires a prescription.
    Start Marketing Date:
    03-14-2024
    Listing Expiration Date:
    12-31-2025
    Exclude Flag:
    N
    Unfinished Product:
    Yes
    Code Structure:

    The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

    * Please review the disclaimer below.

    Frequently Asked Questions

    What is NDC 76617-002-01?

    The NDC Packaged Code 76617-002-01 is assigned to an UNFINISHED drug package of 5 g in 1 bottle of Liraglutide, a bulk ingredient labeled by Hubei Jxbio Pharmaceutical Co., Ltd. The product's dosage form is powder and is administered via form.

    Is NDC 76617-002 included in the NDC Directory?

    Yes, Liraglutide is an UNFINISHED PRODUCT with code 76617-002 that is active and included in the NDC Directory. The product was first marketed by Hubei Jxbio Pharmaceutical Co., Ltd on March 14, 2024 and its listing in the NDC Directory is set to expire on December 31, 2025 if the product is not updated or renewed by the manufacturer.

    What is the 11-digit format for NDC 76617-002-01?

    The 11-digit format is 76617000201. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

    This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

    10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
    5-3-276617-002-015-4-276617-0002-01